ArticleFrontiers in psychology2025
Psychometric properties of the Persian version of the electroconvulsive related anxiety questionnaire for psychiatric patients.
Article in Frontiers in psychology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: ECT is one of the most effective treatments for psychiatric patients. The results of several studies have reported ECT-related anxiety, which makes the patients ignore the advantages of the treatment and subsequently avoid it. Adopting an appropriate instrument to evaluate and manage this anxiety is so significant. Since there is no valid questionnaire to assess the patients' anxiety for ECT in Persian, we aimed to translate the EARQ into Persian and evaluate its validity and reliability in the present study. Methods: In this methodological study, 170 patients with MDD, BMD, and schizophrenia aged 20-73 were recruited through convenience sampling and completed the 17-item EARQ in 2023. We used all aspects of face, content, and construct validity for the questionnaire. McDonald's Omega was calculated for the domains and 17 items to assess the reliability of the questionnaire. Results: Exploratory and confirmatory factor analysis revealed three factors, death anxiety, physical concern, and mental concern. Confirmatory factor analysis indicated moderate fit indices to support the three domains: CMIN/DF = 4.8 ( Conclusions: The EARQ has acceptable validity and reliability, so specialists can use it to assess patients' anxiety before ECT and, according to the score, use suitable interventions to eliminate it.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.